You are here

TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

CMEC Meeting 44, 12 February 2004

Complementary Medicines Evaluation Committee

12 February 2004

Extracted ratified minutes

How to access a pdf document

CMEC Meeting 44 extracted ratified minutes (pdf,105kb)

Public recommendation summary

This summary has been posted immediately after the CMEC meeting to give quick advice of the recommendations made by CMEC to the TGA. This summary does not represent the decisions of TGA. Reasons underlying these recommendations will be available after Members ratify the Minutes at the next CMEC meeting.

Item 2 Minutes of CMEC's 43rd meeting

Recommendation 44.1

CMEC confirms that the draft Minutes of its previous meeting (CMEC 43, 28 November 2003), as amended, are a true and accurate record of that previous meeting.

Item 6.1 Evaluation of new substance: active hexose correlated compound

Recommendation 44.2

CMEC recommends to TGA that, on the basis of the data evaluated, active hexose correlated compound is not suitable for use as an ingredient in listed medicines.

Item 7.1 Safety review: hesperidin

Recommendation 44.3

CMEC noted the review of safety of hesperidin conducted by the TGA and recommends that it is suitable for use as an ingredient in listed medicines.

Item 10.3 Ginseng and pregnancy

Recommendation 44.7

CMEC recommends to TGA that, based on current scientific evidence, ginseng does not require any changes to the way in which it is regulated as an ingredient in listed medicines.

Top of page